SB60 (2017) Detail

Relative to chemical analyses of controlled drugs.


CHAPTER 253

SB 60 - FINAL VERSION

 

20Apr2017... 0938h

06/22/2017   2304CofC

2017 SESSION

17-0771

01/09

 

SENATE BILL 60

 

AN ACT relative to chemical analyses of controlled drugs.

 

SPONSORS: Sen. D'Allesandro, Dist 20; Sen. Lasky, Dist 13; Rep. Welch, Rock. 13

 

COMMITTEE: Health and Human Services

 

-----------------------------------------------------------------

 

AMENDED ANALYSIS

 

This bill establishes a criminal penalty for knowingly making a false entry in a certificate of the results of chemical analyses of controlled drugs.

 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

 

Explanation: Matter added to current law appears in bold italics.

Matter removed from current law appears [in brackets and struckthrough.]

Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.

20Apr2017... 0938h

06/22/2017   2304CofC 17-0771

01/09

 

STATE OF NEW HAMPSHIRE

 

In the Year of Our Lord Two Thousand Seventeen

 

AN ACT relative to chemical analyses of controlled drugs.

 

Be it Enacted by the Senate and House of Representatives in General Court convened:

 

253:1  Controlled Drug Act; Chemical Analysis.  Amend RSA 318-B:26-a, I to read as follows:

I.  Upon the request of the attorney general, a county attorney or any law enforcement agency, the laboratory employee performing the chemical analysis shall prepare a certificate.  The employee shall sign the certificate [under oath] subject to the penalties under this paragraph and shall include in the certificate an attestation as to the result of the analysis.  The presentation of this certificate to a court by any party to a proceeding shall be evidence that all of the requirements and provisions of this section have been complied with.  This certificate shall [be sworn to before a notary public or other person empowered by law to take oaths and shall] contain a statement establishing the following: the type of analysis performed; the result achieved; any conclusions reached based upon that result; that the subscriber is the person who performed the analysis and made the conclusions; the subscriber's training or experience to perform the analysis; and the nature and condition of the equipment used.  When properly executed, the certificate shall, subject to paragraph II of this section and notwithstanding any other provision of law, be admissible evidence of the composition, quality, and quantity of the substance submitted to the laboratory for analysis, and the court shall take judicial notice of the signature of the person performing the analysis and of the fact that he or she is that person.  A person shall be guilty of a class B felony if he or she knowingly makes any false entry in any certificate required under this paragraph.

253:2  Effective Date.  This act shall take effect July 1, 2017.

 

Approved: July 18, 2017

Effective Date: July 01, 2017

Links


Date Body Type
Jan. 24, 2017 Senate Hearing
Feb. 9, 2017 Senate Floor Vote
March 15, 2017 House Hearing
March 29, 2017 House Exec Session
April 20, 2017 House Floor Vote
June 15, 2017 House Floor Vote
June 22, 2017 House Floor Vote
June 22, 2017 Senate Floor Vote

Bill Text Revisions

SB60 Revision: 1622 Date: July 20, 2017, 10:52 a.m.
SB60 Revision: 1623 Date: June 22, 2017, 2:26 p.m.
SB60 Revision: 1624 Date: April 20, 2017, 4:01 p.m.
SB60 Revision: 1625 Date: Jan. 24, 2017, 10:22 a.m.

Docket


July 1, 2017: Signed by the Governor on 07/18/2017; Chapter 0253; Effective 07/01/2017


June 22, 2017: Enrolled (In recess 06/22/2017); SJ 20


June 22, 2017: Enrolled 06/22/2017 HJ 19 P. 27


June 22, 2017: Conference Committee Report # 2017-2304c, Adopted, VV; 06/22/2017; SJ 20


June 22, 2017: Conference Committee Report 2304c: Adopted, VV 06/22/2017 HJ 19 P. 16


June 15, 2017: Conference Committee Report # 2017-2304c Filed 06/15/2017; House Amendment + New Amendment


June 15, 2017: Conferee Change: Rep. Hinch Replaces Rep. Hopper 06/15/2017 HJ 18 P. 10


June 13, 2017: Committee of Conference Meeting: 06/13/2017, 02:00 pm, Room 100, SH


June 1, 2017: Speaker Appoints: Reps. Hagan, Berch, Hopper, R. Graham 06/01/2017 HJ 17 P. 4


June 1, 2017: House Accedes to Senate Request for CofC (Rep. Hagan): MA VV 06/01/2017 HJ 17 P. 4


May 11, 2017: President Appoints: Senators Gray, Avard, D'Allesandro; 05/11/2017; SJ 16


May 11, 2017: Sen. Bradley Moved Nonconcur with the House Amendment; Requests C of C, MA, VV; 05/11/2017; SJ 16


April 20, 2017: Ought to Pass with Amendment 0938h: MA VV 04/20/2017 HJ 14 P. 7


April 20, 2017: Amendment # 2017-0938h: AA VV 04/20/2017 HJ 14 P. 7


April 20, 2017: Committee Report: Ought to Pass with Amendment # 2017-0938h for 04/20/2017 (Vote 17-0; CC) HC 20 P. 6


March 29, 2017: Executive Session: 03/29/2017 LOB 208


March 15, 2017: Public Hearing: 03/15/2017 01:00 PM LOB 208


Feb. 16, 2017: Introduced 02/16/2017 and referred to Judiciary HJ 8 P. 45


Feb. 9, 2017: Ought to Pass: MA, VV; OT3rdg; 02/09/2017; SJ 5


Feb. 9, 2017: Committee Report: Ought to Pass, 02/09/2017; Vote 5-0; CC; SC 9


Jan. 24, 2017: Hearing: 01/24/2017, Room 101, LOB, 01:20 pm; SC 7


Jan. 5, 2017: Introduced 01/05/2017 and Referred to Health and Human Services; SJ 4